We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Relationship of Serum Cortisol and Serum Sodium Analyzed

By LabMedica International staff writers
Posted on 19 Jul 2017
Hyponatremia is the most common electrolyte disorder encountered by the clinical biochemist, and is associated with a significant mortality and hypernatremia is also a risk factor for mortality in critically ill patients.

Adrenal insufficiency is an uncommon cause of hyponatremia, but one that should not be overlooked because an Addisonian crisis, once recognized, can be easily and safely treated with fluid replacement and corticosteroid. More...
Clinical practice guidelines on hyponatremia advise that primary or secondary adrenal insufficiency should always be considered as a potential cause of hyponatremia.

Medical laboratory scientists at the Leeds General Infirmary (Leeds, UK) defined severe hyponatremia as a sodium concentration equal to or less than 120 mmol/L and severe hypernatraemia was defined as a sodium concentration equal to or greater than 150 mmol/L. The reference range for serum cortisol in a morning sample at the Leeds Teaching Hospitals NHS Trust is 150 to 600 nmol/L. Data was gathered on samples where both serum sodium and cortisol that had been requested from the laboratory information management system for 23 months (January 1, 2013, until November 30, 2014).

Serum sodium and cortisol were measured on Advia 1800 or 2400 and Centaur XP analyzers respectively. Analysis of the data from 3,268 patients revealed a trend showing higher cortisol concentrations in patients who were severely hypo- or hypernatremic. The median cortisol concentration for patients with sodium equal to or less than 110 mmol/L was 856 nmol/L, and there was a gradual decrease in cortisol over the sodium range equal to or less than 110 to 150 mmol/L. Patients with sodium equal to or greater than 151 mmol/L had a median cortisol of 725 nmol/L, and 42% of the 978 patients with serum sodium of less than or equal to 120 mmol/L had serum cortisol measured within two weeks, of whom 1.7% were diagnosed with adrenal insufficiency.

The authors concluded that despite the relative rarity of endocrine causes of hyponatremia, adrenal insufficiency should remain an important consideration in the clinical workup of the hypernatremic patient due to the severe consequences of failure to treat with glucocorticoid replacement and volume repletion. The dataset shows rising cortisol in response to hypo- or hypernatremia, in keeping with the stress response to illness. The data show that adrenal insufficiency is a rare cause of hyponatremia, which may be overlooked. The full study will be published in the August 2017 issue of the journal Practical Laboratory Medicine.

Related Links:
Leeds General Infirmary


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.